Reverie Labs
Reverie Labs (YC W18) is building a pharma company from scratch, using computation. Reverie Labs accelerates preclinical drug development by applying machine learning to lead generation & optimization.
Reverie Labs
Reverie Labs (YC W18) is building a pharma company from scratch, using computation. Reverie Labs accelerates preclinical drug development by applying machine learning to lead generation & optimization.
TL;DR
What they do: Machine-learning driven drug discovery focused on accelerating preclinical lead generation and optimization
Founding / YC: Founded 2017; Y Combinator Winter 2018
Funding: Series A (reported Feb 3, 2021); total funding reported ~$25M
Headquarters: Cambridge / Boston area
Company Overview
Problem Domain
Preclinical drug discovery — lead generation and lead optimization
Founded
2017
Industry
Biotechnology / Computational drug discovery
Funding Track Record
Investor Signal
“Raised seed (Mar 2018) with multiple early investors including Y Combinator; later Series A led by Ridgeback Capital”